Drug firm Hetero on Wednesday said it has launched generic oral antiviral drug Favipiravir used for the treatment of patients with mild to moderate COVID-19, in India under the brand name 'Favivir'......
Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......
Pharmaceutical companies, which are sending across medical aid for flood affected people in Jammu and Kashmir, claim to be facing difficulties in distribution of drugs M Srinivas Reddy, director......
Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth......
Hetero Healthcare on Wednesday said is set to deliver 20,000 vials of its antiviral drug Covifor (remdesivir) across the country for the treatment of COVID-19, at a maximum retail price of Rs 5,400......
Roche on Friday announced that it has granted a sub-licence to Hyderabad based Hetero Drugs for the production of oseltamivir (Tamiflu) as part of its continued efforts to increase and speed up......
Hyderabad-based pharma company Hetero Drugs Ltd said on Monday that it had been chosen by the Clinton Research Foundation as one of the four Indian pharmaceutical companies that would supply......
As the battle for the generic market for off-patent drugs in the US intensifies, Indian companies remain at the top in filing drug master files (DMFs) with the US Food and Drug Administration......
Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......
Hetero Drugs, the Hyderabad-based active pharmaceutical ingredients and finished dosages manufacturer, has set up an equal stakes joint venture with Russian pharmaceutical major Makiz Pharma. As......